Mylan Says Cephalon's Patent Win Could Make Generics Scarce
Mylan Pharmaceuticals Inc. has asked the U.S. Supreme Court to review a Federal Circuit decision upholding Cephalon Inc.'s patents for the muscle relaxant Amrix, saying it is a "flawed expansion" of...To view the full article, register now.
Already a subscriber? Click here to view full article